These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25986690)

  • 1. From Protein Communication to Drug Discovery.
    Persico M; Di Dato A; Orteca N; Fattorusso C; Novellino E; Andreoli M; Ferlini C
    Curr Top Med Chem; 2015; 15(20):2019-31. PubMed ID: 25986690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
    Demirel HC; Dogan T; Tuncbag N
    Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.
    Zinzalla G; Thurston DE
    Future Med Chem; 2009 Apr; 1(1):65-93. PubMed ID: 21426071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational ensembles, signal transduction and residue hot spots: application to drug discovery.
    Acuner Ozbabacan SE; Gursoy A; Keskin O; Nussinov R
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):527-37. PubMed ID: 20812144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dynamics of Drug Discovery.
    Moroni E; Paladino A; Colombo G
    Curr Top Med Chem; 2015; 15(20):2043-55. PubMed ID: 26156197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains.
    Hoffer L; Roche P; Morelli X
    Methods Mol Biol; 2021; 2256():277-289. PubMed ID: 34014528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allo-network drugs: extension of the allosteric drug concept to protein- protein interaction and signaling networks.
    Szilágyi A; Nussinov R; Csermely P
    Curr Top Med Chem; 2013; 13(1):64-77. PubMed ID: 23409766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting protein-protein interactions for drug discovery.
    Fry DC
    Methods Mol Biol; 2015; 1278():93-106. PubMed ID: 25859945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocycles as protein-protein interaction inhibitors.
    Dougherty PG; Qian Z; Pei D
    Biochem J; 2017 Mar; 474(7):1109-1125. PubMed ID: 28298556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Interfaces as Targets in Drug Discovery.
    Fattorusso C; Persico M
    Curr Top Med Chem; 2015; 15(20):2003-4. PubMed ID: 26156196
    [No Abstract]   [Full Text] [Related]  

  • 14. CovPDB: a high-resolution coverage of the covalent protein-ligand interactome.
    Gao M; Moumbock AFA; Qaseem A; Xu Q; Günther S
    Nucleic Acids Res; 2022 Jan; 50(D1):D445-D450. PubMed ID: 34581813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural allosteric modulators and their biological targets: molecular signatures and mechanisms.
    Bruder M; Polo G; Trivella DBB
    Nat Prod Rep; 2020 Apr; 37(4):488-514. PubMed ID: 32048675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces.
    Xu D; Si Y; Meroueh SO
    J Chem Inf Model; 2017 Sep; 57(9):2250-2272. PubMed ID: 28766941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modelling as a virtual screening tool for the discovery of small molecule protein-protein interaction inhibitors.
    Voet A; Zhang KY
    Curr Pharm Des; 2012; 18(30):4586-98. PubMed ID: 22650262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
    Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
    ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.